Norway's Crown Princess Mette-Marit has undergone a successful lung transplant, according to the Royal Palace. The 51-year-old princess, who has battled pulmonary fibrosis, a chronic lung disease that progressively scars tissue and restricts breathing, received the transplant as a last-resort treatment for her condition.
The palace confirmed the procedure took place and that Mette-Marit will spend several weeks in hospital during her recovery phase. Pulmonary fibrosis has no cure, making lung transplantation the only viable option for patients in advanced stages. The condition causes irreversible scarring of lung tissue, gradually worsening over time and severely limiting oxygen intake.
Mette-Marit first revealed her diagnosis in 2018, initially stepping back from public duties as her condition deteriorated. She continued limited royal engagements despite her illness, appearing at state functions and official events when her health permitted. The transplant represents a major medical intervention for a member of Europe's working royal families, bringing her case into public focus during the recovery period.
The princess has remained an active member of the Norwegian royal household despite her diagnosis, working on charitable causes and official state business. Her husband, Crown Prince Haakon, and their two children have supported her throughout her health struggles. This transplant decision signals the severity of her pulmonary fibrosis and the necessity of this intervention to extend her life and improve her quality of living.
Norway's healthcare system, consistently ranked among Europe's top medical services, will oversee her recovery at what palace officials describe as a specialized facility equipped for post-transplant care.